| In millions, except per share items | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 | Dec-31-20 |
| | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
| Cash flows from operating activities | | | | | | | | |
| Net loss | -3.1 | -3.4 | -18.5 | -18.9 | 2.3 | 1.1 | 14.9 | 14.2 |
| |
| Adjustments to reconcile net loss to net cash used in operating activities | | | | | | | | |
| Depreciation | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | | | |
| Amortization | 0.4 | 0.3 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 |
| Amortization of debt discount | | | | 0.1 | 0.1 | 0.1 | | |
| Lease expense | | | | 0.0 | | | | |
| Stock based compensation | 0.5 | | | 15.4 | 15.2 | 15.4 | | 0.7 |
| Stock-based compensation – non-employees | | | | | 1.2 | 1.0 | | |
| Shares issued for interest | | 0.0 | | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 |
| Change in fair value of patent acquisition liability | | | | -1.1 | | | | |
| Foreign exchange loss (gain) | | | | 0.0 | 0.1 | 0.2 | 0.2 | 0.1 |
| |
| Changes in operating assets and liabilities which provided (used) cash | | | | | | | | |
| Account Receivables | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | | | |
| Income tax | 0.0 | | | 0.0 | 0.1 | | | |
| Prepaid expenses and other assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | | |
| Other receivable | 0.0 | 0.0 | 0.0 | | | 0.3 | 0.4 | 0.3 |
| Accounts payable | 0.1 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Accounts payable – related parties | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | | | |
| Accrued interest – related and non-related parties | 0.3 | 0.4 | 0.5 | 0.5 | | | | |
| Accrued expenses | -0.5 | -0.3 | -0.1 | -0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Net cash used in operating activities | -0.6 | -0.5 | -0.3 | -0.3 | -0.2 | -0.4 | -0.2 | -0.3 |
| |
| Cash flows used in investing activities | | | | | | | | |
| Cash acquired in acquisition of Clear Com Media Inc | | | | | 0.3 | | | |
| Advances to Cen Biotech Ukraine LLC | | | | | | -0.2 | -0.2 | -0.1 |
| Capitalized software development | | | | -0.1 | -0.1 | | | |
| Purchase of Equipment | | | | 0.0 | 0.0 | | | |
| Net cash provided by (used in) investing activities | | | | 0.0 | 0.0 | -0.3 | -0.1 | -0.1 |
| |
| Cash flows provided by financing activities | | | | | | | | |
| Repayment of loans payable - related parties | | | | | | -0.1 | | |
| Issuance of convertible notes | 0.3 | 0.2 | | 0.5 | 0.4 | 0.7 | | |
| Additional paid in capital | 0.3 | 0.4 | | | | | | |
| Issuance of convertible notes – related parties | 0.5 | | | | | 0.0 | | |
| Net cash provided by financing activities | 1.0 | 0.6 | | 0.5 | 0.4 | 0.6 | 0.4 | 0.5 |
| |
| Supplemental cash flows disclosures | | | | | | | | |
| Cash paid for interest | | | | 0.0 | | 0.1 | | 0.1 |
| |
| Non-cash transactions - investing and financing activities | | | | | | | | |
| |
| Issuance of common stock – upon conversion of convertible notes | | | | | | | | |
| Issuance of common stock – Employee compensation | 0.1 | | | | 0.1 | | | |
| |
| Debt Instrument, Convertible, Beneficial Conversion Feature | | | | | | | | |